ANSI Z80.5 Standard for Prescription Spectacle Frames Updated

ANSI Z80.5 Standard for Prescription Spectacle Frames Updated

Alexandria, VA (September 16, 2010) –  In response to consumer concern regarding health risks of frame materials, the American National Standards Institute (ANSI) last month approved and published an update to the Z80.5 requirement for spectacle frames.

The standard specifies that special attention shall be given to substances which are allergenic, carcinogenic, mutagenic or toxic to reproduction. In addition, new materials not previously used in spectacle frames must be evaluated for biocompatibility before being used.

“Over the past years we’ve seen an increased level of concern regarding the materials, such as lead-based paint, used in the design and manufacture of ophthalmic frames,” said The Vision Council’s Ken Wood, secretariat for ASC Z80. “The update to the Z80.5 standard shows a proactive approach from the optical industry to ensure the health and safety of the end users, the consumers.”

The ANSI Z80.5 standard is overseen by the Z80 Accredited Standards Committee (ASC) for Ophthalmic Optics, which consists of 18 voting organizations and more than 100 experts. The update to the Z80.5 standard for prescription spectacle frames can be purchased at www.webstore.ansi.org.

For more information on the changes to the Z80.5 standard, please contact Amber Robinson, The Vision Council manager of member and technical programs, at (703) 740-1094 or at arobinson@thevisioncouncil.org.

Serving as the global voice for vision care products and services, The Vision Council represents the manufacturers and suppliers of the optical industry. We position our members to be successful in a competitive marketplace through education, advocacy, consumer outreach, strategic relationship building and industry forums.